| For: | Kurimoto N, Inagaki T, Aoki T, Kadotani H, Kurimoto F, Kuriyama K, Yamada N, Ozeki Y. Factors causing a relapse of major depressive disorders following successful electroconvulsive therapy: A retrospective cohort study. World J Psychiatr 2021; 11(10): 841-853 [PMID: 34733646 DOI: 10.5498/wjp.v11.i10.841] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v11/i10/841.htm |
| Number | Citing Articles |
| 1 |
Minna Chang, Allan H. Young, Mario F. Juruena. Comparison of average time-to-relapse following ECT versus ketamine – A systematic review. Journal of Psychopharmacology 2026; 40(6) doi: 10.1177/02698811261430502
|
| 2 |
Marion Plaze, David Attali, Ghita Dadi, Alexandre Haroche. Manuel des troubles bipolaires. 2023; doi: 10.1016/B978-2-294-77180-4.00051-2
|
| 3 |
Octavian Vasiliu. Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder—A Narrative Review. Pharmaceuticals 2023; 16(3) doi: 10.3390/ph16030411
|
| 4 |
Gopalkumar Rakesh, Patrick Cordero, Rebika Khanal, Seth S. Himelhoch, Craig R. Rush. Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis. Journal of Affective Disorders 2024; 358 doi: 10.1016/j.jad.2024.05.037
|
| 5 |
Akise Umakoshi, Masahiro Takeshima, Yu Itoh, Mari Yamamoto, Nana Shibata, Masaya Ogasawara, Naoko Ayabe, Kazuo Mishima. Relationship among psychotic features, benzodiazepine receptor agonists, and rehospitalization in patients with electroconvulsive therapy‐responsive major depressive disorder: A retrospective 2‐year observational study. Neuropsychopharmacology Reports 2022; 42(4) doi: 10.1002/npr2.12282
|